Log In
Print
BCIQ
Print
Print this Print this
 

OT-551

  Manage Alerts
Collapse Summary General Information
Company Colby Pharmaceutical Co.
DescriptionOphthalmic solution of a small molecule NRF-2 regulator
Molecular Target Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat and prevent age-related macular degeneration (AMD); Treat bilateral geographic atrophy (GA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today